Green Growth Brands Valuation
Is GGBX.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PM vs Peers
PM vs Industry
PM vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GGBX.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate GGBX.F's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate GGBX.F's fair value to establish if it is undervalued.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GGBX.F?
Other financial metrics that can be useful for relative valuation.
| What is GGBX.F's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$5.96m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 5.7x |
| Enterprise Value/EBITDA | -3.3x |
| PEG Ratio | n/a |
Ratio vs Peers
How does GGBX.F's Ratio compare to its peers?
| Company | Estimated Growth | Market Cap | |
|---|---|---|---|
| Peer Average | n/a | ||
GGBX.F Green Growth Brands | n/a | n/a | US$6.0m |
PM vs Peers: Insufficient data to calculate GGBX.F's Ratio vs. peers for valuation analysis.
Price to Earnings Ratio vs Industry
How does GGBX.F's PE Ratio compare vs other companies in the US Pharmaceuticals Industry?
Ratio vs Fair Ratio
What is GGBX.F's Ratio compared to its Fair Ratio? This is the expected Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current Ratio | |
| Fair Ratio | n/a |
PM vs Fair Ratio: Insufficient data to calculate GGBX.F's Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.